Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Evenity
Pharma
Amgen doesn't think Repatha's sales wins will stop anytime soon
With Repatha and several other key growth drivers, Amgen has outpaced declines from biosimilar competition to key brands in Q2.
Fraiser Kansteiner
Aug 4, 2026 4:01pm
Repatha helps Amgen overcome Prolia's LOE freefall in Q1
May 1, 2026 8:18am
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Amgen's Prolia flagged by the FDA for risk of hypocalcemia
Jan 19, 2024 3:35pm
Kansas company sues Amgen for alleged infringement with Evenity
Apr 25, 2023 2:46pm
